Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Advanced in vitro lung-on-chip platforms for inhalation assays: From prospect to pipeline.

Artzy-Schnirman A, Hobi N, Schneider-Daum N, Guenat OT, Lehr CM, Sznitman J.

Eur J Pharm Biopharm. 2019 Sep 6. pii: S0939-6411(19)30785-4. doi: 10.1016/j.ejpb.2019.09.006. [Epub ahead of print] Review.

PMID:
31499161
2.

OCTN2-Mediated Acetyl-l-Carnitine Transport in Human Pulmonary Epithelial Cells In Vitro.

Salomon JJ, Gausterer JC, Selo MA, Hosoya KI, Huwer H, Schneider-Daum N, Lehr CM, Ehrhardt C.

Pharmaceutics. 2019 Aug 7;11(8). pii: E396. doi: 10.3390/pharmaceutics11080396.

3.

Vibrational spectroscopic imaging and live cell video microscopy for studying differentiation of primary human alveolar epithelial cells.

Vukosavljevic B, Hittinger M, Hachmeister H, Pilger C, Murgia X, Gepp MM, Gentile L, Huwer H, Schneider-Daum N, Huser T, Lehr CM, Windbergs M.

J Biophotonics. 2019 Jun;12(6):e201800052. doi: 10.1002/jbio.201800052. Epub 2019 Feb 20.

PMID:
30597770
4.

Medium throughput breathing human primary cell alveolus-on-chip model.

Stucki JD, Hobi N, Galimov A, Stucki AO, Schneider-Daum N, Lehr CM, Huwer H, Frick M, Funke-Chambour M, Geiser T, Guenat OT.

Sci Rep. 2018 Sep 25;8(1):14359. doi: 10.1038/s41598-018-32523-x.

5.

Murine alveolar epithelial cells and their lentivirus-mediated immortalisation.

Sapich S, Hittinger M, Hendrix-Jastrzebski R, Repnik U, Griffiths G, May T, Wirth D, Bals R, Schneider-Daum N, Lehr CM.

Altern Lab Anim. 2018 May;46(2):73-89.

PMID:
29856645
6.

In Vitro Model of the Gram-Negative Bacterial Cell Envelope for Investigation of Anti-Infective Permeation Kinetics.

Graef F, Richter R, Fetz V, Murgia X, De Rossi C, Schneider-Daum N, Allegretta G, Elgaher W, Haupenthal J, Empting M, Beckmann F, Brönstrup M, Hartmann R, Gordon S, Lehr CM.

ACS Infect Dis. 2018 Aug 10;4(8):1188-1196. doi: 10.1021/acsinfecdis.7b00165. Epub 2018 May 24.

PMID:
29750862
7.

Co-culture of human alveolar epithelial (hAELVi) and macrophage (THP-1) cell lines.

Kletting S, Barthold S, Repnik U, Griffiths G, Loretz B, Schneider-Daum N, de Souza Carvalho-Wodarz C, Lehr CM.

ALTEX. 2018;35(2):211-222. doi: 10.14573/altex.1607191. Epub 2017 Nov 23.

8.

Nanoencapsulation of a glucocorticoid improves barrier function and anti-inflammatory effect on monolayers of pulmonary epithelial cell lines.

Rigo LA, Carvalho-Wodarz CS, Pohlmann AR, Guterres SS, Schneider-Daum N, Lehr CM, Beck RCR.

Eur J Pharm Biopharm. 2017 Oct;119:1-10. doi: 10.1016/j.ejpb.2017.05.006. Epub 2017 May 13.

PMID:
28512018
9.

Ciprofloxacin-loaded PLGA nanoparticles against cystic fibrosis P. aeruginosa lung infections.

Günday Türeli N, Torge A, Juntke J, Schwarz BC, Schneider-Daum N, Türeli AE, Lehr CM, Schneider M.

Eur J Pharm Biopharm. 2017 Aug;117:363-371. doi: 10.1016/j.ejpb.2017.04.032. Epub 2017 May 2.

PMID:
28476373
10.

Expression and Activity of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Distal Lung Epithelial Cells In Vitro.

Nickel S, Selo MA, Fallack J, Clerkin CG, Huwer H, Schneider-Daum N, Lehr CM, Ehrhardt C.

Pharm Res. 2017 Dec;34(12):2477-2487. doi: 10.1007/s11095-017-2172-9. Epub 2017 May 3.

PMID:
28470471
11.

Barriers and motivations for non-invasive drug delivery.

Loretz B, Schneider-Daum N, Windbergs M, Schaefer U, Schneider M, Lehr CM.

Eur J Pharm Biopharm. 2017 Sep;118:1-2. doi: 10.1016/j.ejpb.2017.04.016. Epub 2017 Apr 19. No abstract available.

PMID:
28433785
12.

Cell and tissue-based in vitro models for improving the development of oral inhalation drug products.

Hittinger M, Schneider-Daum N, Lehr CM.

Eur J Pharm Biopharm. 2017 Sep;118:73-78. doi: 10.1016/j.ejpb.2017.02.019. Epub 2017 Feb 27. Review.

PMID:
28254378
13.

Calcifediol-loaded liposomes for local treatment of pulmonary bacterial infections.

Castoldi A, Herr C, Niederstraßer J, Labouta HI, Melero A, Gordon S, Schneider-Daum N, Bals R, Lehr CM.

Eur J Pharm Biopharm. 2017 Sep;118:62-67. doi: 10.1016/j.ejpb.2016.11.026. Epub 2016 Nov 22.

PMID:
27888144
14.

IL-17A-mediated expression of epithelial IL-17C promotes inflammation during acute Pseudomonas aeruginosa pneumonia.

Wolf L, Sapich S, Honecker A, Jungnickel C, Seiler F, Bischoff M, Wonnenberg B, Herr C, Schneider-Daum N, Lehr CM, Bals R, Beisswenger C.

Am J Physiol Lung Cell Mol Physiol. 2016 Nov 1;311(5):L1015-L1022. doi: 10.1152/ajplung.00158.2016. Epub 2016 Sep 30.

16.

Autologous co-culture of primary human alveolar macrophages and epithelial cells for investigating aerosol medicines. Part I: model characterisation.

Hittinger M, Janke J, Huwer H, Scherließ R, Schneider-Daum N, Lehr CM.

Altern Lab Anim. 2016 Sep;44(4):337-347.

PMID:
27685185
17.

Human alveolar epithelial cells expressing tight junctions to model the air-blood barrier.

Kuehn A, Kletting S, de Souza Carvalho-Wodarz C, Repnik U, Griffiths G, Fischer U, Meese E, Huwer H, Wirth D, May T, Schneider-Daum N, Lehr CM.

ALTEX. 2016;33(3):251-60. doi: 10.14573/altex.1511131. Epub 2016 Mar 17.

18.

Surface-modified yeast cells: A novel eukaryotic carrier for oral application.

Kenngott EE, Kiefer R, Schneider-Daum N, Hamann A, Schneider M, Schmitt MJ, Breinig F.

J Control Release. 2016 Feb 28;224:1-7. doi: 10.1016/j.jconrel.2015.12.054. Epub 2016 Jan 5.

PMID:
26763373
19.

Organic cation transporter function in different in vitro models of human lung epithelium.

Salomon JJ, Gausterer JC, Yahara T, Hosoya K, Huwer H, Hittinger M, Schneider-Daum N, Lehr CM, Ehrhardt C.

Eur J Pharm Sci. 2015 Dec 1;80:82-8. doi: 10.1016/j.ejps.2015.08.007. Epub 2015 Aug 19.

PMID:
26296865
20.

Biological barriers--Advanced drug delivery, in vitro modelling, and their implications for infection research.

Schneider M, Loretz B, Windbergs M, Schneider-Daum N, Schaefer UF, Lehr CM.

Eur J Pharm Biopharm. 2015 Sep;95(Pt A):1-2. doi: 10.1016/j.ejpb.2015.08.003. Epub 2015 Aug 7. No abstract available.

PMID:
26259783

Supplemental Content

Loading ...
Support Center